z-logo
open-access-imgOpen Access
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Author(s) -
Sedighi Mansour,
Zahedi Bialvaei Abed,
Hamblin Michael R.,
Ohadi Elnaz,
Asadi Arezoo,
Halajzadeh Masoumeh,
Lohrasbi Vahid,
Mohammadzadeh Nima,
Amiriani Taghi,
Krutova Marcela,
Amini Abolfazl,
Kouhsari Ebrahim
Publication year - 2019
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.2148
Subject(s) - radiation therapy , medicine , immunotherapy , metastasis , cancer , combination therapy , cancer therapy , chemotherapy , oncology
Successful treatment of cancer remains a challenge, due to the unique pathophysiology of solid tumors, and the predictable emergence of resistance. Traditional methods for cancer therapy including radiotherapy, chemotherapy, and immunotherapy all have their own limitations. A novel approach is bacteriotherapy, either used alone, or in combination with conventional methods, has shown a positive effect on regression of tumors and inhibition of metastasis. Bacteria‐assisted tumor‐targeted therapy used as therapeutic/gene/drug delivery vehicles has great promise in the treatment of tumors. The use of bacteria only, or in combination with conventional methods was found to be effective in some experimental models of cancer (tumor regression and increased survival rate). In this article, we reviewed the major advantages, challenges, and prospective directions for combinations of bacteria with conventional methods for tumor therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom